These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
258 related articles for article (PubMed ID: 31612753)
1. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory. Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753 [TBL] [Abstract][Full Text] [Related]
2. Effects of Long-Term Storage on Serum Free Light Chain Stability. Hörber S; Klein R; Peter A Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238 [TBL] [Abstract][Full Text] [Related]
3. Measurement of free light chains with assays based on monoclonal antibodies. Te Velthuis H; Drayson M; Campbell JP Clin Chem Lab Med; 2016 Jun; 54(6):1005-14. PubMed ID: 27010775 [TBL] [Abstract][Full Text] [Related]
4. Clinical implication by differential analytical performances of serum free light chain quantitation analysis using fully automated analyzers. Yun SY; Rim JH; Park H; Kang H; Lee SG; Lim JB Clin Chem Lab Med; 2023 Jun; 61(7):1288-1299. PubMed ID: 37015073 [TBL] [Abstract][Full Text] [Related]
5. Performance Evaluation of Serum Free Light Chain Analysis: Nephelometry vs Turbidimetry, Monoclonal vs Polyclonal Reagents. Messiaen AS; De Sloovere MMW; Claus PE; Vercammen M; Van Hoovels L; Heylen O; Debrabandere J; Vanpoucke H; De Smet D Am J Clin Pathol; 2017 Jun; 147(6):611-622. PubMed ID: 28575180 [TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice. Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572 [TBL] [Abstract][Full Text] [Related]
7. Development of a rapid and quantitative lateral flow assay for the simultaneous measurement of serum κ and λ immunoglobulin free light chains (FLC): inception of a new near-patient FLC screening tool. Campbell JP; Heaney JL; Shemar M; Baldwin D; Griffin AE; Oldridge E; Goodall M; Afzal Z; Plant T; Cobbold M; Jefferis R; Jacobs JF; Hand C; Drayson MT Clin Chem Lab Med; 2017 Mar; 55(3):424-434. PubMed ID: 27505089 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Impact of Renal Failure on Correlation and Concordance Between 2 Free Light Chain Assays. Moreau C; Autier B; Cavey T; Rouger E; Norwood J; Bendavid C; Escoffre M; Sébillot M; Decaux O Clin Lymphoma Myeloma Leuk; 2016 Dec; 16(12):693-704. PubMed ID: 27618362 [TBL] [Abstract][Full Text] [Related]
10. Clinical specificity of two assays for immunoglobulin kappa and lambda free light chains. Farnsworth CW; Roemmich B; Spears GM; Murray DL; Dispenzieri A; Willrich MAV Clin Chem Lab Med; 2024 Apr; 62(5):929-938. PubMed ID: 38044587 [TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma. Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850 [TBL] [Abstract][Full Text] [Related]
12. Clinical comparison of new monoclonal antibody-based nephelometric assays for free light chain kappa and lambda to polyclonal antibody-based assays and immunofixation electrophoresis. Hoedemakers RM; Pruijt JF; Hol S; Teunissen E; Martens H; Stam P; Melsert R; Te Velthuis H Clin Chem Lab Med; 2011 Nov; 50(3):489-95. PubMed ID: 22098433 [TBL] [Abstract][Full Text] [Related]
13. Serum free light chain analysis: persisting limitations with new kids on the block. Van Hoovels L; Vercammen M; Nevejan L; Cornette M; Briers PJ; Deeren D; Van Droogenbroeck J; Fostier K; De Smet D Clin Chem Lab Med; 2022 Aug; 60(9):1440-1448. PubMed ID: 35781357 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of a new free light chain ELISA assay: bringing coherence with electrophoretic methods. Jacobs JFM; de Kat Angelino CM; Brouwers HMLM; Croockewit SA; Joosten I; van der Molen RG Clin Chem Lab Med; 2018 Jan; 56(2):312-322. PubMed ID: 28771430 [TBL] [Abstract][Full Text] [Related]
15. Method comparison of three serum free light chain assays on the Roche Cobas 6000 c501 chemistry analyzer. Augustijn D; Jacobs JFM; Russcher H Clin Chem Lab Med; 2022 Feb; 60(3):379-385. PubMed ID: 34969184 [TBL] [Abstract][Full Text] [Related]
16. Clinical comparisons of two free light chain assays to immunofixation electrophoresis for detecting monoclonal gammopathy. Kim HS; Kim HS; Shin KS; Song W; Kim HJ; Kim HS; Park MJ Biomed Res Int; 2014; 2014():647238. PubMed ID: 24971342 [TBL] [Abstract][Full Text] [Related]
17. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920 [TBL] [Abstract][Full Text] [Related]
18. Analytical Criticalities Associated to Different Immunological Methods for Serum Free Light Chain Detection in Plasma Cell Dyscrasias: A Description of Particular Clinical Cases. Sabatino R; Perrone A; Cuomo M; Liotti S; Barchiesi V; Cantile M; Cavalcanti E Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417905 [TBL] [Abstract][Full Text] [Related]
19. Assessment of the analytical performance and the sensitivity of serum free light chains immunoassay in patients with monoclonal gammopathy. Wolff F; Thiry C; Willems D Clin Biochem; 2007 Mar; 40(5-6):351-4. PubMed ID: 17239359 [TBL] [Abstract][Full Text] [Related]
20. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains. Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]